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The V243L mutation does not strongly hamper 
production or cause mislocalization of P5CS 
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p<0.05 
Patient fibroblast study carrying the 
dominant V243L mutation 
Human P5CS has a two-residue shorter form (green residues) which is intestinal and 
ornithine-inhibited, while the longer form is widespread and ornithine- insensitive  
• None of the mutant forms exhibited P5CS activity or G5K 
partial activity, except T299I (considered a polymorphism) 
• G5PR partial activity was close to normal 
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Negative dominance could explain the 
dominant inheritance of the disease 
Dominant negative effects require a homooligomeric 
protein architecture. A single mutant subunit would disturb 
the oligomer organization needed for proper function 
Ornithine 
 and proline 
biosynthesis 
Some P5CS patients’ 
mutations cause 
recessive inheritance; 
other mutations cause 
dominant inheritance 
 P5CS mutations (blue lines) was associated 
with a extremely rare cutis laxa, metabolic 
neurodevelopmental syndrome (P5CS 
deficiency, P5CSD; OMIM #219150) with low 
ornithine/citrulline/ proline levels and 
hyperammonemia. In a study of a patient 
(JIMD 2012;35:761) with this syndrome 
having a de novo mutation not found in his 
healthy parents, we proposed a loss of 
function, dominant negative effect to 
account for the dominant inheritance due to 
this de novo mutation. Prior P5CSD 
mutations were all recessive (grey lettering). 
 More recently (Brain 2015, in press), 
spastic paraplegia of dominant inheritance 
SPG9 was associated with P5CS mutations 
(red lines). 
The purpose of this work was to explore the mechanism of disease causation by the mutations reported in P5CSD and in SPG9, using patients 
fibroblasts and in vitro expressed and purified human recombinant P5CS  
 Mutation studied 
experimentally here 
The amount of the 
P5CS protein, 
quantified by Western 
blot,  was decreased 
(~45% ) in the patient  
Fibroblast from a patient  and control, show similar 
mitochondrial pattern, and colocalize with PYCR1, the next 
mitochondrial enzyme in the route of proline biosynthesis 
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Model of the G5K 
domain using as 
template the 
experimental structure 
of the G5K from E. coli 
(PDB 2j5t)  
Dominant disease-associated 
mutations mapping in G5K 
domain (red spheres) sit at the 
domain surface or near it.  
The corresponding E. coli G5K 
residues are involved in the 
interactions with other subunits 
or domains of the bacterial G5K 
oligomer (a tetramer) 
Expression, purification and enzyme 
activity of wild type and mutants of P5CS 
Purification with 
MBP-Trap 
Digestion with 
PreScission 
Cellular extract 
P5CS MBP His 
+ 
P5CS 
Separation 
with His-Trap 
P5CS MBP His 
We use a baculovirus/insect Sf9 cells  system to produce 
recombinant wild type P5CS, dominant or recessive 
mutants located in the G5K domain and the T299I 
polymorphism. 
We measured the activities for both enzymatic steps 
and for the whole reaction. 
 
G5K G5PR 
Pyrroline-5 
carboxylate 
Glutamate L-glutamate-
5 phosphate 
L-glutamate-5-
semialdehyde 
NADPH 
ADP 
NADP+ + Pi  
ATP 
NADH+ H+ 
NAD+  
A340 
Lactate 
Pyruvate 
A340 
Phosphoenol 
pyruvate 
Pyruvate 
kinase 
Lactate 
dehydrogenase 
WT R84Q G93R V243L R252Q T299I 
P5CS 2,11 < 0,07 < 0,07 < 0,07 < 0,07 0,42 
G5K 18,30 < 0,01 < 0,01 0,02 0,03 10,90 
G5PR 2,35 1,09 1,17 1,78 1,90 0,98 
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Global P5CS activity: NADPH consumption in  
presence of glutamate and ATP 
G5K domain activity: ADP production measure 
with Piruvate kinase/Lactate dehydrogenase 
coupled assay 
G5PR domain activity: NADPH consumption in 
presence of an excess of E. coli G5K 
P5CS: domain structure, reactions, role and mutations found 
in patients with cutis laxa or spastic paraplegia 
P5CS is a mitochondrial 
bifunctional enzyme 
Analysis of the oligomeric state of wild type and dominant 
V243L and R252Q mutants by size exclusion chromatography 
P5CS forms 
hexamers 
Mutations V243L and 
R252Q disturb  the 
architecture of P5CS 
resulting in an 
increased tendency of 
the hexamer to 
dissociate to dimers 
Structural considerations 
If dominant mutations disturb the hexamer 
architecture, these are expected to map in regions 
of interaction between different domains/subunits  
ACTIVE INACTIVE 
The lack of P5CS activity in recessive inherited mutations 
explains the pathogenicity of these mutations 
 Polymorphism 
